Your Article Summary
See Latest ArticlesImmunoGen, Inc. Announces Completion of Public Offering of Common Stock
ImmunoGen, Inc., 06/24/09
ImmunoGen, Inc. , a biopharmaceutical company that develops targeted anticancer therapeutics, announced the completion of its previously reported public offering of 5,750,000 shares of common stock. The Company received net proceeds, after underwriting discounts and commissions and estimated expenses, of approximately $38.0 million.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Hospital Launches Portal to Exchange Data
HealthDataManagement, 12/08/09
Bivariate Random Effects Meta-Analysis of Diagnostic Studies Using Generalized Linear Mixed Models
Medical Decision Making, 12/08/09
Cerner Enters R&D Pact with University
HealthDataManagement, 12/08/09